“…The limitation of the clinical design of the study is that we could not compare the GA and MGO values in a control group matched for obesity and the prevalence of diabetes. However, the interpretation of the data that we are supporting here is greatly supported by the large epidemiological studies on COVID-29 syndrome that found a highly significant association of obesity and diabetes with the severity of SARS-CoV-2 infection [ 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 ].…”